CDKN2B and central nervous system cancer: In high-grade human gliomas, often with p15(INK4B) gene deletions, there were varied responses to TGF-β signaling, ranging from mild growth inhibition to stimulation, implicating the loss of p15(INK4B) in the reduced sensitivity of gliomas to TGF-beta’s growth-inhibitory effects [114].